VanEck Pharmaceutical ETF PPH
114.85 USD -0.10 (-0.09%)
Regular-session close
115.00 +0.15 +0.13%
After hours · Nov 20, 4:00 PM ET
114.56 Day range 116.93
97.57 52-week range 122.65
- YTD
- +11.32%
- 1 year
- +16.86%
VanEck Pharmaceutical ETF
- Issuer
- VanEck
- Asset class
- Equity
- Expense ratio
- 0.36%
- Assets under management
- $1.05B
- NAV
- 117.88
- Holdings
- 26
- Inception
- 2011-12-20
- Top 10 weight
- 71.29%
Top holdings
- LLY Eli Lilly & Co 22.95%
- MRK Merck & Co Inc 11.72%
- NVO Novo Nordisk A/S 5.40%
- MCK Mckesson Corp 5.10%
- PFE Pfizer Inc 4.71%
- TEVA Teva Pharmaceutical Industries Ltd 4.70%
- COR Cencora Inc 4.52%
- BMY Bristol-Myers Squibb Co 4.31%
- GSK Gsk Plc 4.19%
- ABBV Abbvie Inc 3.68%
- AZN Astrazeneca Plc 3.68%
- NVS Novartis Ag 3.64%
- SNY Sanofi Sa/France 3.55%
- HLN Haleon Plc 3.45%
- JNJ Johnson & Johnson 3.30%
- TAK Takeda Pharmaceutical Co Ltd 2.94%
- ZTS Zoetis Inc 2.81%
- VTRS Viatris Inc 1.59%
- JAZZ Jazz Pharmaceuticals Plc 1.31%
- ELAN Elanco Animal Health Inc 0.55%
- AXSM Axsome Therapeutics Inc 0.49%
- CORT Corcept Therapeutics Inc 0.42%
- DFTX Definium Therapeutics Inc 0.35%
- OGN Organon & Co 0.27%
- Other/Cash 0.24%
Sector weights
- Healthcare 100.00%
Country weights
- United States 68.43%
- United Kingdom 11.31%
- Denmark 5.54%
- Israel 4.61%
- Switzerland 3.66%
- France 3.54%
- Japan 2.90%
Updated 2026-11-19
Held by funds
4 US ETFs and mutual funds hold PPH · largest positions
